Login to Your Account

‘SINE’ and Dandy: Karyopharm Seeks $80M IPO

By Marie Powers
Staff Writer

Monday, October 7, 2013
The initial public offering (IPO) palooza continued into October with two more filings, including one by Karyopharm Therapeutics Inc. seeking to raise up to $80 million. Karyopharm’s S-1 was filed just two months after the biotech closed a $19 million Series B extension that propelled its venture financing to $97.2 million.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription